Patents by Inventor Janice Au-Young

Janice Au-Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040058426
    Abstract: The invention provides human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonist. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
    Type: Application
    Filed: June 20, 2002
    Publication date: March 25, 2004
    Inventors: Junming Yang, Mariah R. Baughn, Neil Buford, Janice Au-Young, Dyung Aina M Lu, Roopa Reddy, Henry Yue, Monique G Yao, Preeti Lal, Farrah A Khan
  • Publication number: 20040029125
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: October 15, 2002
    Publication date: February 12, 2004
    Inventors: Jennifer L. Policky, April J.A. Hafalia, Neil Burford, Huijun Z. Ring, Preeti Lal, Catherine M. Tribouley, Monique G. Yao, Henry Yue, Y. Tom Tang, Chandra Avvizu, Debopriya Das, Madhu M. Sanjanwala, Ameena R. Gandhi, Roopa Reddy, Farrah A. Khan, Mariah R. Baughn, Jayalaxmi Ramkumar, Jennifer A. Griffin, Janice Au-Young
  • Publication number: 20040023243
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: May 19, 2003
    Publication date: February 5, 2004
    Inventors: Yue Henry, Vicki S Elliott, Ameena R Gandhi, Preeti G Lal, Janice Au-Young, Catherine M Tribouley, Angelo M Delegeane, Mariah R Baughn, Danniel B Nguyen, Ernestine A Lee, April J A Hafalia, Farrah A Khan, Narinder K Chawla, Monique G Yao, Dyung Aina M Lu, Chandra S Arvizu, Y Tom Tang, Roderick T Walsh, Yalda Azimzai, Yan Lu, Jayalaxmi Ramkumar, Yuming Xu, Roopa Reddy, Debopriya Das, Liam Kearney, Deborah A Kallick
  • Publication number: 20040018605
    Abstract: 99 The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
    Type: Application
    Filed: July 25, 2003
    Publication date: January 29, 2004
    Applicant: Incyte Corporation
    Inventors: Janice Au-Young, Benjamin G. Cocks, Roger Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher
  • Publication number: 20040010136
    Abstract: The present invention relates to a composition comprising a plurality of polynucleotide probes. The composition can be used as array elements in a microarray. The present invention also relates to a method for selecting polynucleotide probes of the composition.
    Type: Application
    Filed: November 26, 2002
    Publication date: January 15, 2004
    Applicant: Incyte Genomics, Inc.
    Inventors: Janice Au-Young, Jeffrey J. Seilhamer
  • Publication number: 20030232349
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: October 18, 2002
    Publication date: December 18, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Angelo M. Delegeane, Ameena R. Gandhi, April J. A. Hafalia, Dyung Aina M. Lu, Chandra S. Arvizu, Catherine M. Tribouley, Debopriya Das, Deborah A. Kallick, Danniel B. Nguyen, Ernestine A. Lee, Farrah A. Khan, Henry Yue, Janice Au-Young, Jennifer A. Griffin, Jennifer L. Policky, Jayalaxmi Ramkumar, Junming Yang, Kavitha Thangavelu, Li Ding, Liam Kearney, Mariah R. Baughn, Mark L. Borowsky, Madhusudan Sanjanwala, Monique G. Yao, Neil Burford, Narinder K. Chawla, Preeti G. Lal, Sally Lee, Stephen Todd, Terence P. Lo, Y. Tom Tang, Vicki S. Elliott, Yalda Azimzai, Yan Lu
  • Publication number: 20030220240
    Abstract: The invention provides human vesicle trafficking proteins (VETRP) and polynucleotides which identify and encode VETRP. The invention also provides expession vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expession of VETRP.
    Type: Application
    Filed: December 27, 2002
    Publication date: November 27, 2003
    Inventors: Y. Tom Tang, Henry Yue, Olga Bandman, Jennifer L. Hillman, Mariah R. Baughn, Dyung Aina M. Lu, Yalda Azimzai, Junming Yang, Neil Burford, Janice Au-Young, Roopa Reddy
  • Publication number: 20030215822
    Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
    Type: Application
    Filed: November 15, 2002
    Publication date: November 20, 2003
    Inventors: Jennifer A. Griffin, Monique G. Yao, Christopher M. Bruns, Henry Yue, Angelo M. Delegeane, April Hafalia, Chandra Arvizu, Jennifer L. Policky, Catherine M. Tribouley, Mariah R. Baughn, Danniel B. Nguyen, Preeti Lal, Y. Tom Tang, Jennifer L. Hillman, Dyung Aina M. Lu, Sajeev Batra, Janice Au-Young, Roopa Reddy, Yalda Azimzai
  • Publication number: 20030211493
    Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and en-code GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
    Type: Application
    Filed: July 31, 2002
    Publication date: November 13, 2003
    Inventors: Mariah R Baughn, Janice Au-Young, Henry Yue
  • Publication number: 20030198975
    Abstract: The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
    Type: Application
    Filed: October 31, 2002
    Publication date: October 23, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Yalda Azimzai, Janice Au-Young, Sajeev Batra, Mariah R. Baughn, Shanya D. Becha, Mark L. Borowsky, Neil Burford, Li Ding, Vicki S. Elliott, Brooke M. Emerling, Ameena R. Gandhi, Kimberly J. Gietzen, Jennifer A. Griffin, April J. A. Hafalia, Cynthia D. Honchell, Preeti G. Lal, Soo Yeun Lee, Dyung Aina M. Lu, Chandra S. Arvizu, Jayalaxmi Ramkumar, Roopa M. Reddy, Madhusudan S. Sanjanwala, Y. Tom Tang, Narinder K. Chawla, Yu-Mei E. Wang, Bridget A. Warren, Yuming Xu, Junming Yang, Monique G. Yao, Henry Yue, Yeganeh Zebarjadian
  • Publication number: 20030171275
    Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
    Type: Application
    Filed: June 21, 2002
    Publication date: September 11, 2003
    Inventors: Mariah R. Baughn, Neil Burford, Janice Au-Young, Dyung Aina M. Lu, Junming Yang, Roopa Reddy, Preeti Lal, Jennifer L. Hillman, Yalda Azimzai, Henry Yue, Danniel B. Nguyen, Monique G. Yao, Ameena R. Gandhi, Y. Tom Tang, Farrah A. Khan
  • Publication number: 20030167480
    Abstract: The invention provides cDNA which encode Ndr2-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly cancers of the intestine, breast, uterus, liver, brain, and kidney. The invention additionally provides expression vectors and host cells for the production of the proteins and a transgenic model system.
    Type: Application
    Filed: June 13, 2002
    Publication date: September 4, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Susan G. Stuart, Janice Au-Young, Jennifer L. Hillman, Purvi Shah, Henry Yue
  • Publication number: 20030165989
    Abstract: The invention provides a chemokine receptor-like protein, a cDNA encoding the protein and an antibody which specifically binds the protein. It also provides for the use of the cDNA, protein, and antibodies in the diagnosis, prognosis, treatment and evaluation of therapies for infection, inflammation and cancer, particularly meningioma of the brain. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.
    Type: Application
    Filed: March 18, 2002
    Publication date: September 4, 2003
    Inventors: Janice Au-Young, Karl J. Guegler, Muzong Cheng
  • Publication number: 20030148294
    Abstract: The present invention provides polynucleotides (mmlr-ccr or mphg-ccr) which encode novel chemokine receptors (MMLR-CCR OR MPHG-CCR). The present invention provides for screening methods for the detection of molecules that modulate receptor activity. The present invention also provides for antisense molecules, diagnostic molecules, genetically engineered expression vectors and host cells for the production of purified MMLR-CCR or MPHG-CCR; antibodies, agonists, antagonists and inhibitors of MMLR-CCR or MPHG-CCR; and pharmaceutical compositions and methods of treatment based on the polypeptide, its antibodies, antagonists and inhibitors. The invention further provides diagnostic and therapeutic compositions for the detection and treatment of infection, inflammation, proliferative disease, solid tumors and cardiovascular disease.
    Type: Application
    Filed: March 11, 2002
    Publication date: August 7, 2003
    Inventors: Janice Au-Young, Olga Bandman, Roger Coleman, Craig G. Wilde
  • Publication number: 20030124706
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: June 21, 2002
    Publication date: July 3, 2003
    Inventors: Junming Yang, Mariah R. Baughn, Neil Burford, Janice Au-Young, Dyung Aina M. Lu, Roopa Reddy, Henry Yue, Daniel B. Nguyen, Y. Tom Tang, Monique G. Yao, Preeti Lal
  • Publication number: 20030119111
    Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
    Type: Application
    Filed: August 28, 2002
    Publication date: June 26, 2003
    Inventors: Preeti Lal, Y TOm Tang, Chandra Arvizu, Monique G Yao, Leo L Shih, Catherine M Tribouley, Dyung Aina M Lu, Henry Yue, Farrah A Khan, Jennifer L Policky, Janice Au-Young, Junming Yang, Lee Hardland, Roderick T Walsh, Terence P Lo, Mark L Borowsky
  • Publication number: 20030118995
    Abstract: The present invention provides four human Rab and Rab-associated proteins (designated collectively as HRAB) and polynucleotides which identify and encode HRAB. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HRAB and a method for producing HRAB. The invention also provides for use of HRAB and agonists, antibodies, or antagonists specifically binding HRAB, in the prevention and treatment of diseases associated with expression of HRAB. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HRAB for the treatment of diseases associated with the expression of HRAB. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HRAB.
    Type: Application
    Filed: September 28, 2001
    Publication date: June 26, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Janice Au-Young
  • Publication number: 20030120057
    Abstract: The present invention relates to a composition comprising a plurality of polynucleotide sequences. The composition can be used as probes or array elements.
    Type: Application
    Filed: December 5, 2002
    Publication date: June 26, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Roopa Reddy, Karl J. Guegler, Janice Au-Young
  • Publication number: 20030109674
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode a novel purinergic PU2 receptor (PNR) expressed in human placenta. The present invention also provides for antisense molecules to the nucleotide sequences which encode PNR, expression vectors for the production of purified PNR, antibodies capable of binding specifically to PNR, hybridization probes or oligonucleotides for the detection of PNR-encoding nucleotide sequences, genetically engineered host cells for the expression of PNR, and diagnostic tests based on PNR-encoding nucleic acid molecules or antibodies produced against the polypeptide PNR.
    Type: Application
    Filed: September 11, 2002
    Publication date: June 12, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Roger Coleman, Janice Au-Young, Susan G. Stuart, Karl J. Guegler
  • Publication number: 20030088084
    Abstract: The present invention provides three zinc binding proteins (designated individually as ZB-1, ZB-2, and ZB-3, and collectively as ZB) and polynucleotides which identify and encode ZB. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding ZB and a method for producing ZB. The invention also provides for use of ZB and agonists, antibodies, or antagonists specifically binding ZB, in the prevention and treatment of diseases associated with expression of ZB. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding ZB for the treatment of diseases associated with the expression of ZB. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding ZB.
    Type: Application
    Filed: October 9, 2002
    Publication date: May 8, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Janice Au-Young, Roger Coleman, Surya K. Goli